Beam Therapeutics Inc. held its 2026 annual meeting of stockholders on June 3, 2026, and reported the voting results for director elections, the ratification of Deloitte & Touche LLP as independent auditor, and executive compensation. The elected Class III directors are John Evans, John Maraganore, Ph.D., and Christi Shaw.
